US2003111345A1PendingUtilityA1

Direct detection of histidine tagged biomolecules on electrophoretic gel

Priority: Jul 13, 2000Filed: Jan 28, 2003Published: Jun 19, 2003
Est. expiryJul 13, 2020(expired)· nominal 20-yr term from priority
G01N 27/44726
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method is disclosed for the detection of a His-tagged target biomolecule while said molecule remains in the gel in which it has been separated from other constituents by electrophoresis. The method involves, while the separated His-tagged biomolecule remains in the gel, forming a chelate between the His-tagged molecule, a lanthanide metal ion which exhibits fluorescence, and a sensitizer which enhances the fluorescence of the ion. The gel is then exposed to a u.v. light source to thereby generate a fluorogenic signal indicating the presence of the chelate and, in turn, the His-tagged biomolecule. The fluorogenic signal can then be detected either by direct visualization and/or by other means, such as photographically, e.g., film or charged coupled device (CCD) imaging.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for the direct detection of a histidine tagged biomolecule on an electrophoretic gel comprising (1) separating the biomolecule from other substances by electrophoresis on a gel, (2) while said molecule remains so separated, forming a chelate between said molecule, a lanthanide metal ion which exhibits fluorescence, and a sensitizer which enhances the fluorescence of the ion, and (3) exposing the gel containing said chelate to a u.v. light source thereby generating a fluorescent signal indicative of the presence of the chelate and, in turn, the histidine tagged biomolecule, and (3) detecting the signal so generated.  
     
     
         2 . The method of  claim 1  wherein the lanthanide metal ion is terbium or europium and the sensitizer is a dipicolinic acid.  
     
     
         3 . The method of  claim 2  wherein the lanthanide metal ion is terbium.  
     
     
         4 . The method of  claim 2  or  3  wherein the dipicolinic acid is pyridine, 2,6 dicarboylic acid.  
     
     
         5 . The method of  claim 1  wherein said chelate of the histidine tagged biomolecule, the lanthanide metal ion and the dipicolinic acid is formed by first chelating the histidine tagged biomolecule with the lanthanide metal ion followed by chelation with the sensitizer.  
     
     
         6 . The method of  claim 5  wherein the lanthanide metal ion is terbium or europium and the sensitizer is a dipicolinic acid.  
     
     
         7 . The method of  claim 6  wherein the lanthanide metal ion is terbium.  
     
     
         8 . The method of  claim 6  or  7  wherein the dipicolinic acid is pyridine, 2,6 dicarboylic acid.  
     
     
         9 . A kit for the direct detection of histidine tagged biomolecules on an electrophoretic gel, said kit containing two separately packaged components and a written instruction sheet, one of said components being an aqueous solution of a lanthanide metal ion which exhibits fluorescence and the other of said components being an aqueous solution of a sensitizer which enhances the fluorescence of the ion.  
     
     
         10 . The kit of  claim 9  wherein the lanthanide metal ion is terbium.  
     
     
         11 . The kit of  claim 10  wherein the sensitizer is pyridine, 2,6 dicarboxylic acid.

Join the waitlist — get patent alerts

Track US2003111345A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.